Project TRANSITIONS was a novel demonstration program for managing HIV+ clients as they transitioned from the jail to the community setting. Rapid HIV testing was enhanced within this setting to improve diagnostic screening for HIV.
Project CHOICES was a Targeted Capacity Expansion Program for Substance Abuse Treatment and HIV/AIDS Services (Short Title: TCE/HIV). The program targeted individuals with a history of incarceration who become infected with HIV or who were at risk of acquiring HIV.
Project INSPIRE was a randomized, double-blind, placebo-controlled trial of extended-release injectable naltrexone (Brand name: Vivitrol) for treatment of alcohol dependence and hazardous drinking among HIV-infected individuals transitioning from prison to the community.
Project NEW HOPE was a double-blinded placebo controlled RCT of XR NTX among HIV+ prisoners with opioid dependence who were transitioning from the prison to the community setting.
Project STRIDE was a randomized, controlled trial of buprenorphine among probationers and pre-trial defendants in the greater Washington, D.C. area who met DSM-IV criteria for opioid dependence and who were under community-based criminal justice supervision.
Project HARAPAN was a 2x2 randomized, controlled trial of a prison-based, pre-release methadone program and an evidence-based behavioral intervention (HHRP) for HIV-infected, opioid dependent prisoners in Malaysia.
Project PRIDE was an innovative research initiative that addressed implementation issues related to HIV, substance abuse, and the criminal justice system in Ukraine and states of the former Soviet Union.
Project AHORA-L assessed the feasibility and impact of incorporating interventions to reduce high rates of onward transmission associated with acute HIV infection (AHI) and unsafe sex practices and poor medication adherence due to alcohol use.